Albemarle Completes Sale of Controlling Stake in Ketjen to KPS Capital Partners – Detailed Investor Update
Albemarle Completes Sale of Controlling Stake in Ketjen to KPS Capital Partners
Key Transaction Overview
- Albemarle Corporation (NYSE: ALB), a global leader in the production of lithium and bromine products, has completed the sale of a controlling stake in Ketjen Corporation’s refining catalyst solutions business to affiliates of KPS Capital Partners, LP (KPS).
- Albemarle will retain a minority stake in Ketjen, while KPS takes a majority of the Ketjen Board of Directors and full operational control.
- Albemarle maintains 100% ownership of Ketjen’s Performance Catalyst Solutions business, which has now been integrated into its core product portfolio.
- In a related move, Albemarle recently completed the sale of its 50% interest in the Eurecat joint venture to Axens SA in January 2026.
- Combined, these two transactions have delivered \$670 million in pre-tax proceeds to Albemarle.
- The company intends to use these proceeds primarily for debt reduction and other general corporate purposes.
Strategic and Financial Implications
- Portfolio Focus: These divestitures are part of Albemarle’s ongoing strategy to streamline its portfolio, concentrating on core businesses that support mobility, energy, connectivity, and health.
- Balance Sheet Strengthening: The cash infusion from these deals gives Albemarle more financial flexibility, supporting both debt reduction and future investment capacity.
- Continued Investment in Ketjen: Despite ceding operational control, Albemarle’s retained minority stake in Ketjen signals confidence in its growth and value-creation potential, as emphasized by Chairman and CEO Kent Masters.
- Advisory Team: Goldman Sachs & Co. LLC served as exclusive financial advisor, with K&L Gates LLP as legal advisor for Albemarle in this transaction.
Potentially Price-Sensitive Information for Shareholders
- Proceeds of \$670 million from asset sales strengthen the company’s liquidity and reduce leverage, potentially enhancing Albemarle’s credit profile and enabling future growth investments.
- Strategic Refocusing: The company’s exit from non-core refining catalyst businesses could lead to improved margins and a more resilient, growth-oriented product mix.
- Ongoing Involvement in Ketjen: Albemarle’s minority stake and continued investment alongside KPS may offer upside exposure to future value creation at Ketjen.
- Potential Risks: Forward-looking statements highlight that actual results may vary due to several risk factors, including market volatility, regulatory changes, economic conditions, and the success of integration and divestiture strategies.
About Albemarle and KPS Capital Partners
Albemarle Corporation is a global leader in lithium and bromine, supplying advanced materials for mobility, energy, connectivity, and health. The company regularly posts investor information, news, and SEC filings on its website.
KPS Capital Partners manages approximately \$19.5 billion in assets (as of September 2025) and has a long track record of driving value in manufacturing and industrial businesses, focusing on operational improvements rather than financial leverage.
Forward-Looking Statements and Risks
This announcement contains forward-looking statements regarding Albemarle’s use of transaction proceeds, strategic priorities, value-creation potential, and financial outlook. These statements are based on current assumptions and subject to risks such as changes in business conditions, market volatility, regulatory actions, and other factors detailed in Albemarle’s SEC filings. Investors are advised to consult the company’s most recent reports and remain aware of possible changes in outlook.
Contact Information
Disclaimer: This article is provided for informational purposes only and does not constitute investment advice. Investors should review official filings and consult with their financial advisors before making any investment decisions. The information is based on company disclosures as of March 2026 and is subject to change without notice.
View ALBEMARLE CORP Historical chart here
